Alkermes (ALKS) Other Working Capital Changes (2010 - 2026)
Alkermes (ALKS) posted quarterly Other Working Capital Changes of -$578000.0 for Q3 2025, up 40.53% year-over-year from -$411285.5 in Q3 2024, and up 43.88% quarter-over-quarter from -$1.0 million in Q2 2025.
Alkermes (ALKS) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Other Working Capital Changes for 9 consecutive years, with -$578000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 40.53% year-over-year to -$578000.0; the TTM figure through Dec 2025 stood at -$1.2 million (up 64.57% YoY), while the FY2025 annual figure was -$1.2 million, up 64.57% from the prior year.
- Other Working Capital Changes advanced to -$578000.0 in Q3 2025 per ALKS's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$2.5 million in Q1 2024 and bottomed at -$19.8 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$4.2 million across 5 years, with a median of -$2.8 million in 2026.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 275.07% — and 2025, when it surged 272.6%.
- Alkermes' Other Working Capital Changes stood at -$1.4 million in 2021, then jumped by 243.39% to $2.1 million in 2022, then surged by 222.16% to $6.6 million in 2023, then plunged by 116.41% to -$1.1 million in 2024, then jumped by 46.97% to -$578000.0 in 2025.
- Business Quant data shows ALKS's Other Working Capital Changes at -$578000.0 in Q3 2025, -$1.0 million in Q2 2025, and $359000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.89 Mn |
| Jun 30, 2026 | -2.89 Mn |
| Jun 30, 2026 | -2.89 Mn |
| Mar 31, 2026 | -2.77 Mn |
| Mar 31, 2026 | -2.77 Mn |
| Mar 31, 2026 | -2.77 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -2.53 Mn |
| Dec 31, 2024 | -2.53 Mn |